Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2025-12-25 @ 12:21 AM
NCT ID:
NCT00269958
Eligibility Criteria:
Inclusion Criteria:
* Patients scheduled for elective, first-time hip-replacement surgery or a second hip-replacement surgery (with surgery taking place within 48 hours of the scheduled time)
* having a baseline hemoglobin between 110 and 160 grams per liter
* with no significantly abnormal values for laboratory tests that would indicate an impaired ability to respond to epoetin alfa.
Exclusion Criteria:
* Patients with a primary hematologic disease
* having any clinically significant disease/dysfunction of the neurologic, pulmonary, endocrine, cardiovascular, gastrointestinal, or genitourinary systems
* who have had a seizure disorder in the past 5 years, or who are currently on anticonvulsant therapy
* having uncontrolled high blood pressure
* currently experiencing an ongoing blood loss
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT00269958
Study Brief:
Protocol Section:
NCT00269958